Optimising Disease-Modifying Therapy in People with Multiple Sclerosis

Summary

Dr Kieren Po’s research aims to understand what treatments are being used by people with multiple sclerosis (MS), how treatments are chosen and monitored, how well people stay on treatments and the reasons why. This will be achieved through the analysis of data obtained from people with MS and clinicians.

Ultimately, this research aims to advance understanding of the contemporary MS treatment landscape in different care settings, and may help people with MS and their treating doctors with their treatment decisions.

Updated: 22 February, 2023

Stages of the research process

Fundamental laboratory
Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline: 10+ years

Translational
Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline: 5+ years

Clinical Studies
and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline: 1-5 years